In Vitro and in Vivo Efficacy of a Novel CD33-Targeted Thorium-227 Conjugate for the Treatment of Acute Myeloid Leukemia
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-16-0251
Full Text
Open PDFAbstract
Available in full text
Date
August 17, 2016
Authors
Publisher
American Association for Cancer Research (AACR)